- Home
- RCKT vs CUVL Comparison
RCKT vs CUVL Comparison
Compare RCKT & CUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.52
N/A
Current Price
$7.95
Company Overview
Basic Information| Metric | RCKT | CUVL |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Miscellaneous |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.2M | 347.9M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | RCKT | CUVL |
|---|---|---|
| Price | $3.52 | $7.95 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $29.73 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 4.8K |
| Earning Date | 05-04-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.37 | N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $64.28 | N/A |
| P/E Ratio | $5.27 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.53 | $6.20 |
| 52 Week High | $5.45 | $7.98 |
Technical Indicators
Market Signals| Indicator | RCKT | CUVL |
|---|---|---|
| Relative Strength Index (RSI) | 53.49 | 64.53 |
| Support Level | $3.32 | $6.58 |
| Resistance Level | $3.65 | N/A |
| Average True Range (ATR) | 0.18 | 0.27 |
| MACD | 0.01 | 0.09 |
| Stochastic Oscillator | 62.51 | 89.89 |
Price Performance
Historical Comparison RCKT
CUVL
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.